Literature DB >> 32051546

Rab5a activates IRS1 to coordinate IGF-AKT-mTOR signaling and myoblast differentiation during muscle regeneration.

Xiao Xia Cong1,2, Xiu Kui Gao1,2, Xi Sheng Rao1,2, Jie Wen1,2, Xiao Ceng Liu1,2, Yin Pu Shi1,2, Min Yi He1,2, Wei Liang Shen1,2, Yue Shen1, Hongwei Ouyang1,2,3,4, Ping Hu5, Boon Chuan Low6, Zhuo Xian Meng7, Yue Hai Ke7, Ming Zhu Zheng8, Lin Rong Lu2,3,8, Yong Heng Liang9, Li Ling Zheng10,11, Yi Ting Zhou12,13,14,15.   

Abstract

Rab5 is a master regulator for endosome biogenesis and transport while its in vivo physiological function remains elusive. Here, we find that Rab5a is upregulated in several in vivo and in vitro myogenesis models. By generating myogenic Rab5a-deficient mice, we uncover the essential roles of Rab5a in regulating skeletal muscle regeneration. We further reveal that Rab5a promotes myoblast differentiation and directly interacts with insulin receptor substrate 1 (IRS1), an essential scaffold protein for propagating IGF signaling. Rab5a interacts with IRS1 in a GTP-dependent manner and this interaction is enhanced upon IGF-1 activation and myogenic differentiation. We subsequently identify that the arginine 207 and 222 of IRS1 and tyrosine 82, 89, and 90 of Rab5a are the critical amino acid residues for mediating the association. Mechanistically, Rab5a modulates IRS1 activation by coordinating the association between IRS1 and the IGF receptor (IGFR) and regulating the intracellular membrane targeting of IRS1. Both myogenesis-induced and IGF-evoked AKT-mTOR signaling are dependent on Rab5a. Myogenic deletion of Rab5a also reduces the activation of AKT-mTOR signaling during skeletal muscle regeneration. Taken together, our study uncovers the physiological function of Rab5a in regulating muscle regeneration and delineates the novel role of Rab5a as a critical switch controlling AKT-mTOR signaling by activating IRS1.

Entities:  

Year:  2020        PMID: 32051546      PMCID: PMC7370222          DOI: 10.1038/s41418-020-0508-1

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  56 in total

Review 1.  Myoblast fusion: lessons from flies and mice.

Authors:  Susan M Abmayr; Grace K Pavlath
Journal:  Development       Date:  2012-02       Impact factor: 6.868

Review 2.  Myogenic progenitor cells and skeletal myogenesis in vertebrates.

Authors:  Margaret Buckingham
Journal:  Curr Opin Genet Dev       Date:  2006-08-22       Impact factor: 5.578

Review 3.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

4.  Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.

Authors:  Mickaël Ohanna; Andrew K Sobering; Thomas Lapointe; Lazaro Lorenzo; Christophe Praud; Emmanuel Petroulakis; Nahum Sonenberg; Paul A Kelly; Athanassia Sotiropoulos; Mario Pende
Journal:  Nat Cell Biol       Date:  2005-02-20       Impact factor: 28.824

5.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.

Authors:  S C Bodine; T N Stitt; M Gonzalez; W O Kline; G L Stover; R Bauerlein; E Zlotchenko; A Scrimgeour; J C Lawrence; D J Glass; G D Yancopoulos
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

6.  Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin.

Authors:  J Tureckova; E M Wilson; J L Cappalonga; P Rotwein
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

Review 7.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.

Authors:  Francesco Saverio Tedesco; Arianna Dellavalle; Jordi Diaz-Manera; Graziella Messina; Giulio Cossu
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

8.  Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice.

Authors:  Yasuhiro Izumiya; Teresa Hopkins; Carl Morris; Kaori Sato; Ling Zeng; Jason Viereck; James A Hamilton; Noriyuki Ouchi; Nathan K LeBrasseur; Kenneth Walsh
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

9.  Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.

Authors:  Valérie Risson; Laetitia Mazelin; Mila Roceri; Hervé Sanchez; Vincent Moncollin; Claudine Corneloup; Hélène Richard-Bulteau; Alban Vignaud; Dominique Baas; Aurélia Defour; Damien Freyssenet; Jean-François Tanti; Yannick Le-Marchand-Brustel; Bernard Ferrier; Agnès Conjard-Duplany; Klaas Romanino; Stéphanie Bauché; Daniel Hantaï; Matthias Mueller; Sara C Kozma; George Thomas; Markus A Rüegg; Arnaud Ferry; Mario Pende; Xavier Bigard; Nathalie Koulmann; Laurent Schaeffer; Yann-Gaël Gangloff
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

10.  Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors.

Authors:  Marta L Hribal; Jun Nakae; Tadahiro Kitamura; John R Shutter; Domenico Accili
Journal:  J Cell Biol       Date:  2003-08-18       Impact factor: 10.539

View more
  6 in total

1.  Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes.

Authors:  Xiu Kui Gao; Xi Sheng Rao; Xiao Xia Cong; Zu Kang Sheng; Yu Ting Sun; Shui Bo Xu; Jian Feng Wang; Yong Heng Liang; Lin Rong Lu; Hongwei Ouyang; Huiqing Ge; Jian-Sheng Guo; Hang-Jun Wu; Qi Ming Sun; Hao-Bo Wu; Zhang Bao; Li Ling Zheng; Yi Ting Zhou
Journal:  Cell Discov       Date:  2022-06-28       Impact factor: 38.079

2.  Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis.

Authors:  Rubing Bai; Artur Rebelo; Jörg Kleeff; Yoshiaki Sunami
Journal:  Lipids Health Dis       Date:  2021-06-02       Impact factor: 3.876

3.  Beta-hydroxy-beta-methylbutyrate associated with low-intensity exercise training improves skeletal muscle regeneration through the IGF-Akt pathway.

Authors:  A K Yamada; R Ferretti; C Y Matsumura; L Antunes; C A da Silva; A Pertille
Journal:  Braz J Med Biol Res       Date:  2022-01-05       Impact factor: 2.590

Review 4.  Regulatory role of RNA N6-methyladenosine modifications during skeletal muscle development.

Authors:  Baojun Yu; Jiamin Liu; Juan Zhang; Tong Mu; Xiaofang Feng; Ruoshuang Ma; Yaling Gu
Journal:  Front Cell Dev Biol       Date:  2022-08-05

5.  AMPK-mediated phosphorylation enhances the auto-inhibition of TBC1D17 to promote Rab5-dependent glucose uptake.

Authors:  Xi Sheng Rao; Xiao Xia Cong; Xiu Kui Gao; Yin Pu Shi; Lin Jing Shi; Jian Feng Wang; Chen-Yao Ni; Ming Jie He; Yingke Xu; Cong Yi; Zhuo-Xian Meng; Jinling Liu; Peng Lin; Li Ling Zheng; Yi Ting Zhou
Journal:  Cell Death Differ       Date:  2021-05-27       Impact factor: 15.828

6.  The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways.

Authors:  L Coudert; A Osseni; Y G Gangloff; L Schaeffer; P Leblanc
Journal:  BMC Biol       Date:  2021-07-30       Impact factor: 7.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.